Percentage of bloodstream infection due to Escherichia coli resistant in Mali

Mali: Percentage of bloodstream infection due to Escherichia coli resistant was 60.9% in 2022. ▲ Rising

Latest (2022)
60.9%
Change on year
up 31.2%
World rank
10th
of 50 countries
All-time high
60.9%
in 2022
All-time low
32.0%
in 2018
Years of data
5
2018–2022

Percentage of bloodstream infection due to Escherichia coli resistant in Mali, 2018–2022

02040602018202020222018: 32 %2019: 39.7 %2020: 60.8 %2021: 46.4 %2022: 60.9 %

Source: United Nations Statistics Division, SDG Global Database. Measured in %.

Analysis

The most recent figure for percentage of bloodstream infection due to escherichia coli resistant in Mali is 60.9%, measured in 2022. That is the highest value across all 5 years on record.

Compared with earlier readings it is up 31.2% on the previous year and up 89.9% over five years.

That places Mali 10th out of 50 countries with data for 2022, putting it in the top quarter.

Percentage of bloodstream infection due to Escherichia coli resistant in Mali, year by year

Annual values for Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%) in Mali, 2018 to 2022.
Year % Change
2018 32.0%
2019 39.7% +24.0%
2020 60.8% +53.0%
2021 46.4% -23.7%
2022 60.9% +31.3%

Averages by decade

DecadeAverage LowestHighest Years
2010s 35.9% 32.0% 39.7% 2
2020s 56.0% 46.4% 60.9% 3

Countries ranked near Mali

  1. 7 Iran (Islamic Republic of) 70.6% compare
  2. 8 Indonesia 69.7% compare
  3. 9 Bahrain 63.0% compare
  4. 11 North Macedonia 60.0% compare
  5. 12 Sri Lanka 58.8% compare
  6. 13 Russian Federation 58.5%
  7. 13 Russian Federation 58.5%

See the full ranking of 66 places →

More development goals data for Mali

All data for Mali →

Frequently asked questions

What is percentage of bloodstream infection due to escherichia coli resistant in Mali?
Percentage of bloodstream infection due to escherichia coli resistant in Mali was 60.9% in 2022, according to United Nations Statistics Division, SDG Global Database.
What is the highest percentage of bloodstream infection due to escherichia coli resistant recorded in Mali?
The highest recorded value was 60.9% in 2022.
What is the lowest percentage of bloodstream infection due to escherichia coli resistant recorded in Mali?
The lowest recorded value was 32.0% in 2018.
How does Mali rank for percentage of bloodstream infection due to escherichia coli resistant?
Mali ranks 10th out of 50 countries with data for 2022.
Where does this Mali data come from?
The figures come from United Nations Statistics Division, SDG Global Database, published as part of Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 5 observations, free to reuse under UN SDG Global Database (open, attribution requested).

Share, cite or embed this page

Cite this page

Percentage of bloodstream infection due to Escherichia coli resistant in Mali. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 08 September 2026, from https://development-goals.statizoid.com/stat/percentage-of-bloodstream-infection-due-to-escherichia-coli-resistant-to-3rd-generation/mali/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://development-goals.statizoid.com/stat/percentage-of-bloodstream-infection-due-to-escherichia-coli-resistant-to-3rd-generation/mali/">Percentage of bloodstream infection due to Escherichia coli resistant in Mali</a> — Statizoid

About this data

Indicator
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%)
Unit
%
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
66 places, 407 data points, 2016–2022
Last refreshed